H. The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J. Gen. Intern. Med. 9, 445–449 (1994). Article CAS PubMed Google Scholar Thatipelli, M. R. et al. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for ...
improving microcirculation in impaired vascular beds, inhibiting platelet aggregation, improving red-cell deformability, and reducing whole-blood and plasma viscosity. It has been used for years in Europe as a treatment for claudication, despite what Olin referred to as "underwhelming" evidence supporting...
Vascular Distal Peripheral Microembolism Joe P. Chauvapun, MD; Maciej Dryjski, MD, PhD Disclosures Vascular. 2005;13(1):50-57. 0Surgical Therapy In the presence of occlusive disease, surgical treatment of spontaneous atheroembolism remains the standard of care. The goal of surgical therapy ...
Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease ...
Poly-caprolactone; PLCL: Poly-lactidecaprolactone; ATF-3: Activating Transcription Factor-3; FGF: Fibroblast growth factor; NGF: Nerve growth factor; IGF: Interleukin-like growth factor; CNTF: Ciliary neurotrophic factor; BDNF: Brain-derived neurotrophic factor; VEGF: Vascular endothelial growth factor...
A second phase III trial confirmed this protective effect by sodium thiosulfate against cisplatin-induced hearing loss in children,50 but a lower survival rate was seen in the subgroup of patients with disseminated disease. This observation might suggest that sodium thiosulfate is tumour protective in...
Nerve growth factor (NGF), Fibroblast growth factor (FGF), Ciliary neurotrophic factor (CNTF), Interleukin-like growth factor (IGF), Vascular endothelial growth factor (VEGF), and Brain-derived neurotrophic factor (BDNF) The expression of a large number of neurotropic factors/growth factors increas...
PAD is also a major risk factor for lower-extremity amputation, especially in patients with diabetes. Moreover, even for the asymptomatic patient, PAD is a marker for systemic vascular disease involving coronary, cerebral, and renal vessels, leading to an elevated risk of events, such as myocard...
NICE explains that the ankle brachial pressure should be measured with the person resting and supine if possible, and that measurements should be taken manually using a doppler probe of suitable frequency in preference to an automated system. The index in each leg should be calculated by dividing...
The Heart Protection Study demonstrated a decrease in cardiovascular events (i.e., total mortality, vascular mortality, coronary heart disease events, strokes and noncoronary revascularizations) over 5 years with simvastatin 40 mg in over 20,000 patients with and without known PAD.[10]A notable ...